On January 6, 2021 AVEO Oncology (Nasdaq: AVEO) reported that Michael Bailey, president and chief executive officer of AVEO, will participate in two upcoming virtual investor conferences (Press release, AVEO, JAN 6, 2021, View Source [SID1234573577]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright Virtual BioConnect Conference
Date: Monday, January 11 – Thursday, January 14

B. Riley Virtual Oncology Investor Conference
Date: Wednesday, January 20
Time: 1:30 PM Eastern Time

A replay of the pre-recorded H.C. Wainwright presentation can be accessed on Monday, January 11, 2021 in the investors section of the Company’s website at www.aveooncology.com, and a live webcast of the B. Riley presentation can be accessed in the same section of the Company’s website. A replay of the webcasts will be archived for 30 days following the presentation date.